FDA approves STAAR's Visian Toric ICL for myopia with astigmatism

STAAR Surgical’s Visian Toric Implantable Collamer Lens has been approved by the FDA for the correction of myopia with astigmatism, according to a company press release.

The approval expands the company’s ICL indications, the release said.

“FDA’s approval of STAAR’s Visian Toric ICL in the U.S. provides an exciting treatment option for myopic patients with astigmatism in search of visual freedom,” STAAR President and CEO Caren Mason said in the release.

The Visian Toric ICL is expected to be available in the U.S. on Nov. 1, the release said.

STAAR Surgical’s Visian Toric Implantable Collamer Lens has been approved by the FDA for the correction of myopia with astigmatism, according to a company press release.

The approval expands the company’s ICL indications, the release said.

“FDA’s approval of STAAR’s Visian Toric ICL in the U.S. provides an exciting treatment option for myopic patients with astigmatism in search of visual freedom,” STAAR President and CEO Caren Mason said in the release.

The Visian Toric ICL is expected to be available in the U.S. on Nov. 1, the release said.